Details for 2018705239

Up to date per 14.05.2026

Actions

Title / Product Name

KRISTALLINE FORMEN VON TENOFOVIR-ALAFENAMID

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2018705239

EP Publication Number

3577125

E-Number

1686856

Language

PCT Number

US18015770

Publication Date

11.12.2019 A

15.05.2024 B1

Registration Date

15.05.2024

AT Publication Date

15.06.2024

Application Date

29.01.2018

Registration Number

Priorities

31.01.2017

201762452428 P

IPC

C07F 9/6561 20060101AFI20180810BHEP

Maximum Duration of Protection

29.01.2038

Owner

Gilead Sciences, Inc.333 Lakeside Drive Foster City, CA 94404US

Representative

SONN Patentanwälte GmbH & Co KGRiemergasse 141010 WienAT

Inventor

LAI, Chiajenc/o Gilead Sciences Inc. 333 Lakeside Drive Foster City, CA 94404US

SHI, Bingc/o Gilead Sciences Inc. 333 Lakeside Drive Foster City, CA 94404US

STRICKLEY, Robert, G.1399 Parrott Drive San Mateo, CA 94402US

Information about Fees